Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
The drugmaker says it will apply for FDA approval although safety concerns remain → Read More
In the midst of a public mental health crisis, providers are leaving the field due to burnout → Read More
The latest Youth Risk Behavior Survey portrays a generation that is not so interested in sex → Read More
A study found the quantities of melatonin typically wildly exceed what is stated in labels → Read More
A lack of data on booster performance among kids has prompted complex federal guidelines → Read More
A lack of data on booster performance among kids has prompted complex federal guidelines → Read More
Giorgia Meloni's administration plans to protect Italian by fining the use of other languages → Read More
The pandemic isn't even over yet, and governments are already cutting funding to initiatives that would prepare us for the next one. → Read More
Could employing formerly incarcerated people as community health workers improve community health and end mass incarceration? → Read More
New WHO data shows steady increase in rates of maternal deaths in the country since 2000 → Read More
A lack of financial incentive for pharma companies means many will die from a preventable disease → Read More
The White House will end the emergency on May 11. Here's how things will change. → Read More
Nursing homes are losing both money and staff, leaving those in need with few options. → Read More
Most of the people who struggle to get insulin will continue to do so with a copay cap → Read More
The company projects revenue from covid products drop by as much as 64% → Read More
High rates of police stops in a New Orleans neighborhood resulted in increased risk of preterm birth among Black mothers → Read More
Updated rules make the drug available in pharmacies, but the drug is still subject to too many restrictions → Read More
Nirmacom, a combination of nirmatrelvir and ritonavir, will be available for prescription in 95 low- and middle-income countries → Read More
The first BioNTainer, which will start producing mRNA vaccines in 2024, is ready to go to Kigali → Read More
Africa CDC will start reporting vaccination rates of people aged 12 or more instead of the total population → Read More